Advertisement
Research Article

Efficacy of Short-Course AZT Plus 3TC to Reduce Nevirapine Resistance in the Prevention of Mother-to-Child HIV Transmission: A Randomized Clinical Trial

  • James A. McIntyre,

    Affiliation: Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa

    X
  • Mark Hopley,

    Affiliation: Boehringer Ingelheim, Johannesburg, South Africa

    X
  • Daya Moodley,

    Affiliation: Department of Obstetrics and Gynaecology, Nelson Mandela School of Medicine, University of KwaZulu Natal, Durban, South Africa

    X
  • Marie Eklund,

    Affiliation: Boehringer Ingelheim, Johannesburg, South Africa

    X
  • Glenda E. Gray,

    Affiliation: Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa

    X
  • David B. Hall,

    Affiliation: Boehringer Ingelheim Pharmaceuticals, Ridgefield, Connecticut, United States of America

    X
  • Patrick Robinson,

    Affiliation: Boehringer Ingelheim Pharmaceuticals, Ridgefield, Connecticut, United States of America

    X
  • Douglas Mayers,

    Affiliation: Boehringer Ingelheim Pharmaceuticals, Ridgefield, Connecticut, United States of America

    Current address: Idenix Pharmaceuticals, Cambridge, Massachusetts, United States of America

    X
  • Neil A. Martinson mail

    martinson@hivsa.com

    Affiliations: Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America

    X
  • Published: October 27, 2009
  • DOI: 10.1371/journal.pmed.1000172
  • Published in PLOS Medicine

Viewed info

Cited info

Saved info

Discussed info

Questions or concerns about usage data? Please let us know.